Evidence map›Paper›PMID 23071502›Full record

ArticlePloS one2012

Similarities between exogenously- and endogenously-induced envelope stress: the effects of a new antibacterial molecule, TPI1609-10.

Shmuel Yitzhaki, Jason E Rostron, Yan Xu, Marc C Rideout, R Nathan Authement, Steven B Barlow, Anca M Segall

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Shmuel YitzhakiDepartment of Biology and Center for Microbial Sciences, San Diego State University, San Diego, California, United States of America.
Jason E Rostron
Yan Xu
Marc C Rideout
R Nathan Authement
Steven B Barlow
Anca M Segall
San Diego State University · US

Funding

Novel antibiotics that trap Holliday junctionsR01AI058253 · NIAID · SAN DIEGO STATE UNIVERSITY · PI SEGALL, ANCA MARA · 2004 to 2008
$2.3M
NIAID NIH HHS R01 AI058253
6 · The paper itself

Abstract

Antibiotics with novel and/or multiple targets are highly desirable in the face of the steady rise of clinical antibiotic resistance. We have screened and identified small molecules, typified by the compound TPI1609-10 (aka SM10), with antibiotic activity against both gram-positive and gram-negative bacteria. SM10 was screened in vitro to bind branched Holliday junction intermediates of homologous recombination and tyrosine recombinase-mediated recombination; thus, the cellular targets of the small molecules were expected to include the RuvABC Holliday junction resolvasome and the XerCD complex involved in proper segregation of replicated chromosomes to daughter cells. SM10 indeed induces DNA damage and filamentation in E. coli. However, SM10 also induces envelope stress and causes increased production of intracellular reactive oxygen species. In addition, SM10 has similar effects to endogenously-induced envelope stress via overproducing outer membrane proteins (OmpC and OmpF), which also induces the SOS response, chromosome fragmentation, and production of reactive oxygen species. The synergy between SM10, and cerulenin, a fatty acid synthesis inhibitor, together with the SM10 hypersensitivity of cpx and rpoE mutants, further support that SM10's mode of action damages membrane damage. The lethality of SM10 treatment and of OmpC overproduction are observed in both aerobically- and anaerobically-grown cells, and is accompanied by substantial DNA damage even anaerobically. Thus, only some DNA damage is due to reactive oxygen. We propose that membrane depolarization and the potential reduction in intracellular pH, leading to abasic site formation, cause a substantial amount of the DNA damage associated with both SM10 treatment and endogenous envelope stress. While it is difficult to completely exclude effects related to envelope damage as the sources of DNA damage, trapping intermediates associated with DNA repair and chromosome segregation pathways remains very likely. Thus SM10 may have distinct but synergistic modes of action.

Indexed as

Anti-Bacterial AgentsBarbituratesCell MembraneCeruleninDNA, CruciformDNA DamageEscherichia coliEscherichia coli ProteinsEthanolImidazolidinesIndolesIsoxazolesNaphthalenesPorinsReactive Oxygen SpeciesSOS Response, GeneticsAnti-Bacterial AgentsBarbituratesbis(1,3-dibutylbarbiturate)trimethine oxonolCeruleninDNA, CruciformEscherichia coli ProteinsEthanolImidazolidinesindoleIndolesIsoxazolesNaphthalenesOmpC proteinOmpF proteinPorinsReactive Oxygen SpeciesTPI1609-10

Identifiers

PMID23071502
PMCPMC3469575
OpenAlexW1979029891

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.